Health X Platform Ltd
National Stock Exchange of IndiaTotal Valuation
Health X Platform Ltd carries a market capitalization of 9.80B, placing it among publicly traded companies globally. Its enterprise value stands at 9.37B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 9.80B |
| Enterprise Value | 9.37B |
Share Statistics
Health X Platform Ltd currently has 31.81M shares outstanding.
| Shares Outstanding | 31.81M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Health X Platform Ltd trades at a trailing price-to-earnings ratio of 697.70. The price-to-sales ratio is 0.63, and the price-to-book ratio stands at 1.28.
| PE Ratio | 697.70 |
| PS Ratio | 0.63 |
| PB Ratio | 1.28 |
| P/TBV Ratio | 1.35 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
| EV / Sales | 0.72 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 1,953.00 |
Financial Position
Health X Platform Ltd maintains a current ratio of 2.22, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.35, indicating elevated leverage, while an interest coverage ratio of -90.01 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.22 |
| Quick Ratio | 0.33 |
| Debt / Equity | 3.35 |
| Debt / EBITDA | -0.36 |
| Interest Coverage | -90.01 |
Financial Efficiency
| Return on Equity (ROE) | 0.18 |
| Return on Assets (ROA) | 0.12 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 9.48 |
Taxes
Over the trailing twelve months, Health X Platform Ltd has paid -9.10M in income taxes, reflecting an effective tax rate of 71.77.
| Income Tax | -9.10M |
| Effective Tax Rate | 71.77 |
Stock Price Statistics
Health X Platform Ltd's stock has gained approximately 8.28059% over the past 52 weeks. The 50-day moving average sits at 312.62, while the 200-day moving average is 297.89.
| Beta (5Y) | N/A |
| 52-Week Price Change | 8.28059% |
| 50-Day Moving Average | 312.62 |
| 200-Day Moving Average | 297.89 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Health X Platform Ltd generated 13.08B in revenue and converted that into 11.76M in net income, yielding earnings per share of -0.45. EBITDA reached -703.58M, while operating income came in at -703.58M.
| Revenue | 13.08B |
| Gross Profit | 992.25M |
| Operating Income | -703.58M |
| Pretax Income | -23.58M |
| Net Income | 11.76M |
| EBITDA | -703.58M |
| EBIT | -703.58M |
| Earnings Per Share (EPS) | -0.45 |
Balance Sheet
Health X Platform Ltd holds 302.16M in cash and equivalents against 256.57M in total debt, resulting in a net debt position of -80.97M. Total book value stands at 6.41B, with working capital of 1.11B providing operational flexibility.
| Cash & Cash Equivalents | 302.16M |
| Total Debt | 256.57M |
| Net Debt | -80.97M |
| Equity (Book Value) | 6.41B |
| Book Value Per Share | 201.47 |
| Working Capital | 1.11B |
Margins
Health X Platform Ltd operates with a gross margin of 7.59, reflecting its pricing power and cost economics. The operating margin of -5.38 and net profit margin of 0.09 provide insight into operational efficiency.
| Gross Margin | 7.59 |
| Operating Margin | -5.38 |
| Pretax Margin | -0.18 |
| Profit Margin | 0.09 |
| EBITDA Margin | -5.38 |
Scores
Health X Platform Ltd posts an Altman Z-Score of 4.22, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.22 |